1 min read
Add as a preferred source on Google

Eli Lilly to Buy Calytrix Bio in All-Cash Deal Worth Up to $1.5 Billion

Calytrix Bio is a privately held biotechnology company, and the transaction is structured as an all-cash deal.

Two glass sample vials rest beside a sealed white envelope. / TokenPost.ai
Two glass sample vials rest beside a sealed white envelope. / TokenPost.ai

Eli Lilly will buy privately held biotechnology company Calytrix Bio in an all-cash deal with a maximum stated value of $1.5 billion.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…